Clinical trial
Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya: A Three-arm Pragmatic Randomized Study on the Effectiveness, Feasibility, Acceptability, and Cost.
NCT05944731 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya: A Three-arm Pragmatic Randomized Study on the Effectiveness, Feasibility, Acceptability, and Cost.
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- September 3, 2023
- Completion date
- October 10, 2026
- Enrollment
- 246 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes